ReACH Assistant/ Associate/Professor Opening

Please visit our Job Opportunities page for more information about this exciting opportunity! 

ReACH Scholar, Dr. Carlos Jaén named to the board of National Library of Medicine

ReACH Scholar Carlos Jaén, MD, PhD, professor and chair of family and community medicine in the Joe R. & Teresa Lozano Long School of Medicine, has been appointed to the board of regents of the National Library of Medicine of the National Institutes of Health. Dr. Jaén’s special interests include improving preventive care for individuals of all ages, preventing complications from chronic diseases like diabetes, high blood pressure and heart disease.



ReACH Director, Dr. Barbara J. Turner featured on Texas Public Radio's Texas Standard

On Friday, March 31st, Dr. Barbara J. Turner, the Director of the Center for Research to Advance Community Health (ReACH) will be featured on the Texas Public Radio show Texas Standard to discuss a recently published study that looks at how much the Hispanic community knows about chronic pain.  Dr. Turner and her team conducted a population-based survey representing 8.8 million Hispanic residents of five Southwestern states who did not have chronic pain.  The data from this study reveal serious gaps in knowledge about chronic pain including misunderstanding about relying on narcotics to treat the disease. This is the first study to reveal poor knowledge about chronic pain in a large population of Americans and reinforces the urgency of launching a broad-based educational campaign about chronic pain and its care. 

Contact Us

7411 John Smith Road

Suite 1050

San Antonio, TX



Tel: 210-562-5551

Fax: 210-562-5560

Alarming new CDC numbers on viral hepatitis in the United States

Last month, the Centers for Disease Control and Prevention (CDC) released new surveillance data on viral hepatitis in the United States. 

The numbers paint a grim picture.

  • From 2010 to 2016, reported cases of acute hepatitis C (HCV) increased 3.5-fold.
  • Between 2015 and 2016, the number of reported cases of HCV increased 21.8 percent.
  • In 2016, an estimated 41,200 new HCV infections were reported.
  • In 2016, American Indians/Alaska Natives had the highest HCV-related mortality rate compared with other racial/ethnic populations, and persons aged 55–64 years had the highest HCV-related mortality rate compared with other age groups.

These data confirm that high rates of injection drug use, lack of sterile equipment, and the unavailability of testing and treatment for lower-income and incarcerated people contribute to the epidemic of viral hepatitis.  

The ReACH Center has several ongoing programs that strive to Screen, Treat, or Prevent (STOP) liver cancer and failure in Texans through one-time baby boomer screening for HCV, education and community collaboration, practice transformation in medically underserved areas with a lack of access to specialist care and policy advocacy.  To learn more about our STOP HCC-HCV program please visit